Diagnostic Medical Systems (XPAR:ALDMS) Net Margin %: 0.00% (As of Dec. 2025)


XPAR:ALDMS Diagnostic Medical Systems XPAR:ALDMS
68 GF Score
Price €1.25
GF Value €1.14
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Diagnostic Medical Systems Net Margin %?

Diagnostic Medical Systems XPAR:ALDMS -1.57% 68 Net Margin % is 0.00% as of Dec. 2025. GuruFocus rates XPAR:ALDMS with a GF Score™ of 68/100 and a GF Value™ of €1.14 (Fairly Valued). The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Diagnostic Medical Systems ranks worse than 61.32% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Diagnostic Medical Systems's Net Income for the six months ended in Dec. 2025 was €0.00 Mil. Diagnostic Medical Systems's Revenue for the six months ended in Dec. 2025 was €0.00 Mil. Therefore, Diagnostic Medical Systems's net margin for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Diagnostic Medical Systems's Net Margin % or its related term are showing as below:

XPAR:ALDMS' s Net Margin % Range Over the Past 10 Years
Min: -22.2   Med: -10.35   Max: -0.33
Current: -6.25


XPAR:ALDMS's Net Margin % is ranked worse than
61.32% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: 2.09 vs XPAR:ALDMS: -6.25

Diagnostic Medical Systems  (XPAR:ALDMS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Diagnostic Medical Systems Net Margin % Related Terms


Diagnostic Medical Systems Net Margin % Historical Data

* Premium members only.

The historical data trend for Diagnostic Medical Systems's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnostic Medical Systems Net Margin % Chart

Diagnostic Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.68 -19.34 -11.73 -6.25 -0.33

Diagnostic Medical Systems Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.14 -40.88 -6.26 -6.24 0.00

XPAR:ALDMS vs ABT, SYK, MDT: Net Margin % Comparison

For the Medical Devices subindustry, Diagnostic Medical Systems's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diagnostic Medical Systems Net Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's Net Margin % distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's Net Margin % falls into.


XPAR:ALDMS
68GF Score
Diagnostic Medical Systems XPAR:ALDMS
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnostic Medical Systems Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Diagnostic Medical Systems's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.167/49.974
=-0.33 %

Diagnostic Medical Systems's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Diagnostic Medical Systems (XPAR:ALDMS) has a Net Margin % of 0.00% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on Diagnostic Medical Systems and its competitors. According to the industry distribution chart, Diagnostic Medical Systems ranks #501 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 61.3%.
Is Diagnostic Medical Systems' Net Margin % too high?
Diagnostic Medical Systems' current Net Margin % is 0.00%. Based on the distribution chart, Diagnostic Medical Systems ranks #501 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Diagnostic Medical Systems has a GF Score™ of 68/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Diagnostic Medical Systems' Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diagnostic Medical Systems ranks #501 out of 817 companies for Net Margin %. This places Diagnostic Medical Systems in the lower half of its industry. The industry median Net Margin % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.09, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Diagnostic Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diagnostic Medical Systems's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnostic Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Diagnostic Medical Systems (XPAR:ALDMS) is currently considered Fairly Valued. The stock's GF Value™ is €1.14, compared to a current price of €1.25 — trading 9.6% above its estimated fair value. The current Net Margin % is 0.00%. Diagnostic Medical Systems' overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Diagnostic Medical Systems (XPAR:ALDMS), the current Net Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnostic Medical Systems (XPAR:ALDMS) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnostic Medical Systems stock appears to be overvalued. The current stock price of €1.25 is trading 9.6% above its estimated GF Value™ of €1.14. GuruFocus considers Diagnostic Medical Systems to be Fairly Valued.

Key valuation signals for XPAR:ALDMS:

  • Net Margin %: 0.00%
  • GF Value™: €1.14 vs. price of €1.25 (9.6% above fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the XPAR:ALDMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diagnostic Medical Systems Business Description

Other Exchanges 0RIA:UKDMS1:Germany
Address 9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660
Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.
68GF Score

Get the complete analysis for XPAR:ALDMS

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.25
Price
€1.14
GF Value